Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:55 pm Purchase | 2025-03-31 | 13G | SURROZEN INC SRZN | RA CAPITAL MANAGEMENT L.P. | 867,418 9.900% | 543,756 (+168.00%) | Filing History |
| 2025-05-15 4:55 pm Unchanged | 2025-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA CAPITAL MANAGEMENT L.P. | 2,866,733 8.900% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:53 pm Sale | 2025-03-31 | 13G | CHIMERIX INC CMRX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -8,800,000 (Position Closed) | Filing History |
| 2025-05-15 4:53 pm Unchanged | 2025-03-31 | 13G | UROGEN PHARMA LTD URGN | RA CAPITAL MANAGEMENT L.P. | 3,206,271 7.000% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:52 pm Sale | 2025-03-31 | 13G | C4 THERAPEUTICS INC CCCC | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,878,000 (Position Closed) | Filing History |
| 2025-05-15 4:51 pm Purchase | 2025-03-31 | 13G | VAXCYTE INC PCVX | RA CAPITAL MANAGEMENT L.P. | 12,964,491 9.900% | 314,763 (+2.49%) | Filing History |
| 2025-05-15 4:51 pm Sale | 2025-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | RA CAPITAL MANAGEMENT L.P. | 206,427 2.900% | -254,402 (-55.21%) | Filing History |
| 2025-05-15 4:49 pm Purchase | 2025-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | RA CAPITAL MANAGEMENT L.P. | 1,094,407 9.900% | 127,108 (+13.14%) | Filing History |
| 2025-05-15 4:49 pm Sale | 2025-03-31 | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 6,011,112 7.100% | -1,766,830 (-22.72%) | Filing History |
| 2025-05-15 4:48 pm Sale | 2025-03-31 | 13G | ADAGIO MED INC ADGM | RA CAPITAL MANAGEMENT L.P. | 1,200,000 7.200% | -413,220 (-25.61%) | Filing History |
| 2025-05-14 6:34 pm Purchase | 2025-05-12 | 13D | ITEOS THERAPEUTICS INC. ITOS | RA CAPITAL MANAGEMENT L.P. | 4,163,276 9.900% | 504,230 (+13.78%) | Filing History |
| 2025-05-14 6:09 pm Purchase | 2025-05-12 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 6,746,807 15.000% | 553,926 (+8.94%) | Filing History |
| 2025-05-09 4:19 pm Purchase | 2025-05-07 | 13D | LENZ THERAPEUTICS INC LENZ | RA CAPITAL MANAGEMENT L.P. | 4,260,606 15.100% | 9,750 (+0.23%) | Filing History |
| 2025-04-30 4:51 pm Purchase | 2025-04-28 | 13D | JADE BIOSCIENCES, INC. JBIO | RA CAPITAL MANAGEMENT L.P. | 1,324,954 4.100% | 1,060,894 (+401.76%) | Filing History |
| 2025-04-04 4:32 pm Purchase | 2025-03-28 | 13G | SUTRO BIOPHARMA INC STRO | RA CAPITAL MANAGEMENT L.P. | 443,464 5.300% | 443,464 (New Position) | Filing History |
| 2025-03-31 4:57 pm Purchase | 2025-03-27 | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA CAPITAL MANAGEMENT L.P. | 15,016,063 24.800% | 34,445 (+0.23%) | Filing History |
| 2025-03-31 4:54 pm Purchase | 2025-03-27 | 13D | TYRA BIOSCIENCES INC TYRA | RA CAPITAL MANAGEMENT L.P. | 10,684,890 20.100% | 7,750 (+0.07%) | Filing History |
| 2025-03-17 7:58 pm Purchase | 2025-03-13 | 13D | MINERALYS THERAPEUTICS INC MLYS | RA CAPITAL MANAGEMENT L.P. | 6,287,597 9.900% | 1,338,290 (+27.04%) | Filing History |
| 2025-03-10 4:33 pm Purchase | 2025-03-06 | 13D | JANUX THERAPEUTICS INC JANX | RA CAPITAL MANAGEMENT L.P. | 11,971,377 19.900% | 1,528,196 (+14.63%) | Filing History |
| 2025-03-03 8:17 pm Unchanged | 2025-02-27 | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 20,013,733 13.700% | 0 (Unchanged) | Filing History |